Literature DB >> 11992642

Variation in the kinetics of caspase-3 activation, Bcl-2 phosphorylation and apoptotic morphology in unselected human ovarian cancer cell lines as a response to docetaxel.

Geertruida M Kolfschoten1, Theresia M Hulscher, Monique C A Duyndam, Herbert M Pinedo, Epie Boven.   

Abstract

Paclitaxel is able to cause cell death through the induction of apoptosis. Cell death characteristics for docetaxel have not yet been described in detail. We investigated four unselected human ovarian cancer cell lines for the sensitivity to a 1hr exposure to docetaxel and calculated the concentrations inhibiting 50% (IC(50)) and 90% (IC(90)) of cell growth. Of the cell lines A2780, H134, IGROV-1 (all wild-type p53) and OVCAR-3 (mutant, mt p53) A2780 was most sensitive and OVCAR-3 least sensitive. Equitoxic drug concentrations representing IC(90) values (25-510nM) were applied for 1hr to measure cell cycle distribution, DNA degradation, and to count apoptotic cell bodies and cells with multifragmented nuclei at various time-points after drug exposure. H134, IGROV-1 and OVCAR-3 showed a continued mitotic block up to at least 72hr and prolonged presence of cells with multifragmented nuclei. High percentages of apoptosis were calculated at 48hr and at later time-points. In contrast, A2780 cells accumulated in the S-phase of the cell cycle and apoptosis was hardly present. The changes in the expression levels of p53, p21/WAF1, Bax and Bcl-2, were not predictive for docetaxel-induced apoptosis. Caspase-3 activation occurred only in cells with accumulation in the G2/M phase starting as early as 8hr in OVCAR-3. Prolonged Bcl-2 phosphorylation was evident in OVCAR-3, visible at 24hr in H134 and IGROV-1, while this phenomenon did not occur in A2780. The mitogen-activated protein kinase pathway (JNKs/SAPKs or c-Jun N-terminal kinases/stress-activated protein kinases, JNK1/2; extracellular response kinase, ERK1/2; p38) did not seem to be directly involved in Bcl-2 phosphorylation or apoptosis. We conclude that docetaxel is able to activate caspase-3, induce Bcl-2 phosphorylation and apoptosis in cells that show a prolonged G2/M arrest, but cells may also die by a caspase-3-independent cell death mechanism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11992642     DOI: 10.1016/s0006-2952(01)00895-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  11 in total

1.  Regulation of microtubule, apoptosis, and cell cycle-related genes by taxotere in prostate cancer cells analyzed by microarray.

Authors:  Yiwei Li; Xingli Li; Maha Hussain; Fazlul H Sarkar
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

2.  Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells.

Authors:  Jyotsnabaran Halder; Charles N Landen; Susan K Lutgendorf; Yang Li; Nicholas B Jennings; Dominic Fan; Gina M Nelkin; Rosemarie Schmandt; Michael D Schaller; Anil K Sood
Journal:  Clin Cancer Res       Date:  2005-12-15       Impact factor: 12.531

3.  Comparison of cell death-inducing effect of novel taxane SB-T-1216 and paclitaxel in breast cancer cells.

Authors:  Jan Kovár; Marie Ehrlichová; Barbora Smejkalová; Ilaria Zanardi; Iwao Ojima; Ivan Gut
Journal:  Anticancer Res       Date:  2009-08       Impact factor: 2.480

4.  [11C]Choline as pharmacodynamic marker for therapy response assessment in a prostate cancer xenograft model.

Authors:  Bernd J Krause; Michael Souvatzoglou; Ken Herrmann; Axel W Weber; Tibor Schuster; Andreas K Buck; Roman Nawroth; Gregor Weirich; Uwe Treiber; Hans-Jürgen Wester; Sibylle I Ziegler; Reingard Senekowitsch-Schmidtke; Markus Schwaiger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-05-30       Impact factor: 9.236

5.  Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells.

Authors:  Haitao Luo; Gary O Rankin; Lingzhi Liu; Matthew K Daddysman; Bing-Hua Jiang; Yi Charlie Chen
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

6.  Genome-wide discovery of loci influencing chemotherapy cytotoxicity.

Authors:  James W Watters; Aldi Kraja; Melissa A Meucci; Michael A Province; Howard L McLeod
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-28       Impact factor: 11.205

7.  Gene expression profiling revealed novel mechanism of action of Taxotere and Furtulon in prostate cancer cells.

Authors:  Yiwei Li; Maha Hussain; Sarah H Sarkar; James Eliason; Ran Li; Fazlul H Sarkar
Journal:  BMC Cancer       Date:  2005-01-18       Impact factor: 4.430

8.  The chemomodulatory effects of glufosfamide on docetaxel cytotoxicity in prostate cancer cells.

Authors:  Reem T Attia; Mai F Tolba; Ruchit Trivedi; Mariane G Tadros; Hossam M M Arafa; Ashraf B Abdel-Naim
Journal:  PeerJ       Date:  2016-06-29       Impact factor: 2.984

9.  Baker's Yeast Sensitizes Metastatic Breast Cancer Cells to Paclitaxel In Vitro.

Authors:  Nariman K Badr El-Din; Ashraf Z Mahmoud; Tahia Ali Hassan; Mamdooh Ghoneum
Journal:  Integr Cancer Ther       Date:  2017-11-21       Impact factor: 3.279

10.  Aqueous Extract of Solanum nigrum Leaf Activates Autophagic Cell Death and Enhances Docetaxel-Induced Cytotoxicity in Human Endometrial Carcinoma Cells.

Authors:  Cheng-Jeng Tai; Chien-Kai Wang; Yu-Jia Chang; Chi-Shian Lin; Chen-Jei Tai
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-08       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.